Literature DB >> 8905554

Reduction in erythrocyte complement receptor 1 (CR1, CD35) and decay accelerating factor (DAF, CD55) during normal pregnancy.

H J Imrie1, T P McGonigle, D T Liu, D R Jones.   

Abstract

RBC-membrane CR1 has been assayed in pregnancy and at 48 h postpartum. It has been shown that RBC CR1 is reduced as pregnancy progress, reaching a nadir in the third trimester and that it returns to levels approaching normal within 48 h postpartum. Further, there is a reduced expression of RBC decay accelerating factor (DAF) during pregnancy but no change in expression of RBC CD59. We suggest that the reduction in RBC CR1 and DAF may reflect increased levels of circulating immune complexes and consequent increased complement activation in pregnancy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8905554     DOI: 10.1016/0165-0378(96)00977-1

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  9 in total

Review 1.  Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis.

Authors:  J E Salmon; G Girardi; V M Holers
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

2.  Multimodal immune phenotyping of maternal peripheral blood in normal human pregnancy.

Authors:  Richard Apps; Yuri Kotliarov; Foo Cheung; Kyu Lee Han; Jinguo Chen; Angélique Biancotto; Ashley Babyak; Huizhi Zhou; Rongye Shi; Lisa Barnhart; Sharon M Osgood; Yasmine Belkaid; Steven M Holland; John S Tsang; Christa S Zerbe
Journal:  JCI Insight       Date:  2020-04-09

3.  Normal pregnancy is characterized by systemic activation of the complement system.

Authors:  Karina Richani; Eleazar Soto; Roberto Romero; Jimmy Espinoza; Tinnakorn Chaiworapongsa; Jyh Kae Nien; Samuel Edwin; Yeon Mee Kim; Joon-Seok Hong; Moshe Mazor
Journal:  J Matern Fetal Neonatal Med       Date:  2005-04

Review 4.  Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications.

Authors:  A M Lynch; J E Salmon
Journal:  Placenta       Date:  2010-04-27       Impact factor: 3.481

5.  Maternal coding variants in complement receptor 1 and spontaneous idiopathic preterm birth.

Authors:  Jude J McElroy; Courtney E Gutman; Christian M Shaffer; Tamara D Busch; Hilkka Puttonen; Kari Teramo; Jeffrey C Murray; Mikko Hallman; Louis J Muglia
Journal:  Hum Genet       Date:  2013-04-17       Impact factor: 4.132

Review 6.  Preeclampsia, hypoxia, thrombosis, and inflammation.

Authors:  Amir A Shamshirsaz; Michael Paidas; Graciela Krikun
Journal:  J Pregnancy       Date:  2011-12-11

Review 7.  Emerging and Novel Functions of Complement Protein C1q.

Authors:  Lubna Kouser; Shanmuga Priyaa Madhukaran; Abhishek Shastri; Anuvinder Saraon; Janez Ferluga; Maha Al-Mozaini; Uday Kishore
Journal:  Front Immunol       Date:  2015-06-29       Impact factor: 7.561

Review 8.  Emerging infections and pregnancy.

Authors:  Denise J Jamieson; Regan N Theiler; Sonja A Rasmussen
Journal:  Emerg Infect Dis       Date:  2006-11       Impact factor: 6.883

Review 9.  Influenza in pregnancy.

Authors:  Matthew J Memoli; Hillery Harvey; David M Morens; Jeffery K Taubenberger
Journal:  Influenza Other Respir Viruses       Date:  2012-11-21       Impact factor: 4.380

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.